GLP-1 Weight Loss for PCOS
Polycystic ovary syndrome (PCOS) is a hormonal disorder affecting 6-12% of women of reproductive age, making it one of the most common causes of weight gain and difficulty losing weight in women. PCOS disrupts insulin signaling, leading to insulin resistance that promotes fat storage -- particularly around the midsection. Many women with PCOS find that traditional diets and exercise alone are not enough to achieve meaningful weight loss. The hormonal imbalances caused by PCOS create a metabolic environment where the body actively resists shedding excess weight.
GLP-1 treatment for patients with PCOS. Prescribed by licensed providers, delivered to your door. Compounded medications are not FDA-approved.
From 2,000+ patients · PCOS is already seeing results
Semaglutide and tirzepatide are the active ingredients in FDA-approved GLP-1 medications (Wegovy®, Zepbound®) whose clinical trials of the FDA-approved brand-name products studied populations that included patients with PCOS. PCOS affects approximately Affects 6-12% of women of reproductive age of U.S. adults. Weight Method offers compounded programs starting at $199/month with virtual consultations and direct shipping. Compounded medications are not FDA-approved.
How do GLP-1 medications help with this condition?
GLP-1 receptor agonists like semaglutide and tirzepatide address the root metabolic dysfunction behind PCOS-related weight gain. These medications improve insulin sensitivity, helping your body process glucose more efficiently instead of storing it as fat. Clinical studies show that women with PCOS who take GLP-1 medications experience significant reductions in body weight, waist circumference, and androgen levels. By breaking the cycle of insulin resistance, GLP-1 therapy can also help restore regular ovulation and improve fertility outcomes for women trying to conceive.
Who qualifies for treatment?
Women with PCOS who have a BMI of 27 or higher are generally strong candidates for GLP-1 weight loss treatment. Because PCOS is closely linked to insulin resistance and metabolic dysfunction, your provider may consider you eligible even at a lower BMI if other metabolic markers are present. Weight Method's online assessment evaluates your full health profile to determine the best treatment plan.
How It Works
Take the Quiz
Answer questions about your health and medical condition.
Virtual Consultation
A provider will review your case and create a personalized plan.
Get Your Medication
Your GLP-1 medication ships directly to your door.
Your Treatment Options
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.
